Drug Shortage Report for LUTREPULSE PWS 0.8MG/VIAL
| Report ID | 220371 |
| Drug Identification Number | 02046210 |
| Brand name | LUTREPULSE PWS 0.8MG/VIAL |
| Common or Proper name | GONADORELIN ACETATE |
| Company Name | FERRING INC |
| Market Status | MARKETED |
| Active Ingredient(s) | GONADORELIN ACETATE |
| Strength(s) | 0.8MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS |
| Packaging size | 1 x 10 mL vial of 0.8 mg |
| ATC code | H01CA |
| ATC description | HYPOTHALAMIC HORMONES |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2024-06-30 |
| Actual start date | 2024-06-30 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2024-02-23 |
| Company comments | Product is no longer available past expiry of current stock in Canada due to manufacturing line decomissioning. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 200 YORKLAND BLVD TORONTO, ONTARIO CANADA M2J 5C1 |
| Company contact information | 1-800-263-4057 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2024-02-23 | French | Compare |
| v1 | 2024-02-23 | English | Compare |
Showing 1 to 2 of 2